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Abstract
Background: Despite the large burden of Plasmodium vivax, little is known about its transmission dynamics. This
study explored the population structure and spatio-temporal dynamics of P. vivax recurrent infections after radical
cure in a two-year cohort study carried out in a rural community of the Peruvian Amazon.
Methods: A total of 37 P. vivax participants recruited in San Carlos community (Peru) between April and December
2008 were treated radically with chloroquine and primaquine and followed up monthly for two years with
systematic blood sampling. All samples were screened for malaria parasites and subsequently all P. vivax infections
genotyped using 15 microsatellites. Parasite population structure and dynamics were determined by computing
different genetic indices and using spatio-temporal statistics.
Results: After radical cure, 76% of the study participants experienced one or more recurrent P. vivax infections,
most of them sub-patent and asymptomatic. The parasite population displayed limited genetic diversity (He = 0.49)
and clonal structure, with most infections (84%) being monoclonal. Spatio-temporal clusters of specific haplotypes
were found throughout the study and persistence of highly frequent haplotypes were observed over several
months within the same participants/households.
Conclusions: In San Carlos community, P. vivax recurrences were commonly observed after radical treatment, and
characterized by asymptomatic, sub-patent and clustered infections (within and between individuals from a few
neighbouring households). Moreover low genetic diversity as well as parasite inbreeding are likely to define a clonal
parasite population which has important implications on the malaria epidemiology of the study area.
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Background
Plasmodium vivax, the most widely distributed malaria
species, threatens almost 40% of the worldwide popula-
tion [1]. Vivax malaria is less benign than commonly
thought [1] and, due to its complex life cycle, which in-
cludes liver hypnozoites that can be re-activated well
after the primary infection, it is difficult to have a clear
picture of its burden and epidemiology. Limited know-
ledge of the underlying P. vivax population structure
and dynamics are major obstacles to achieve effective
malaria control, particularly in low endemic areas [2]. In
the Peruvian Amazon, vivax malaria is still a major pub-
lic health problem [3]. Both chloroquine-resistant strains
[4] and the frequent occurrence of recurrent infections
after ‘radical’ treatment [chloroquine (CQ) and prima-
quine (PQ)] have been reported [4,5]. Moreover, the fre-
quent occurrence of clustered asymptomatic infections
makes malaria control in this low endemic setting ex-
tremely difficult [6-8]. Therefore, there is the need to
carry out P. vivax population genetic studies to under-
stand how parasites are circulating in the human popu-
lation, as well as related topics such as the spread of
drug resistance and the development of clinical immun-
ity [9,10]. Similar to other endemic Amazonian countries
[11-13], P. vivax populations in the Peruvian Amazon
are extremely heterogeneous, with different degrees of
diversity and polyclonality [14,15]. This study was part
of a larger ongoing P. vivax cohort conducted within 21
rural communities, and which results will be published
later. In this paper, one of these study villages has been
selected in order to analyse, at community and house-
hold level, the population structure and the spatial-
temporal dynamics of P. vivax infections after radical
treatment of the primary infection.
Methods
Study site
The study was conducted in San Carlos (latitude 3°57′
30.99″S longitude 73°20′45.76″W), a relatively small
and isolated village in the Peruvian Amazon, situated at
10 km from the main road (Iquitos-Nauta road) and
21 km southeast of Iquitos city (six hours by boat via
the Itaya river) [14] (Figure 1). Malaria transmission is
perennial with a peak during the rainy season (November–
May). About 80% of malaria cases are caused by P.
vivax, and Anopheles darlingi is the main vector [7,16].
The 127 habitants of San Carlos (2008 census) were pri-
marily ‘mestizos’ (individuals not belonging to a specific
ethnic minority) living in open wooden houses (average of
4.7 persons/house), mainly occupied in slash and burn
agriculture and small scale fishery [17]. Households are
situated close (13–45 m) to each other with the maximal
distance between any two households being of less than
1 km (V Soto-Calle, pers comm). Neither electricity nor
basic sanitation services are available, and the closest
health post was approximately 3 km away from San Carlos
community.
Sample collection
Plasmodium vivax-infected participants were identified
by microscopy examination of blood smears collected
during an initial screening of the village population
(April 2008) followed by active case detection of all fever
cases (April to December 2008), following the study
protocol of the larger cohort study. All microscopically
confirmed P. vivax-infected participants were treated
(directly observed treatment) with CQ 25 mg/kg/day
(three days) and PQ 0.50 mg/kg/day (seven days), fol-
lowing the national guidelines for radical cure [5]. The
most important limitation for the seven-day regimen in
the Peruvian Amazon is the adherence to the treatment
[18]. For this reason, the treatment was administered in
a supervised way by a health care worker (hired exclu-
sively for this study) and monitored every day during the
seven-day treatment. Participants were asked their writ-
ten informed consent (parents/guardians for minors) to
be monthly follow-up for two years in order to detect P.
vivax recurrent infections. Study subjects were visited at
home weekly for the first month after treatment, and
then monthly for the next 23 months. If a participant
missed one scheduled sampling, the health care worker
came back to the community two more times to look for
the participant and/or scheduled the most feasible time
to visit. At each visit, the medical staff asked study par-
ticipants about any symptoms they may have had since
the previous visit. A blood sample for microscopy (thick
and thin film) and a blood spot on filter paper (BSFP)
(Whatman grade 3, Whatman, Springfield Mill, USA)
for later molecular analysis were systematically collected.
Figure 1 Map of the study area. A. Map of the study area, San
Carlos community, located at the southeast of Iquitos city, capital of
the Peruvian Amazon. B. Picture of a typical household in San Carlos
community belonging to one P. vivax-infected participant
(Photography provided by A Erhart).
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Between scheduled visits, participants were encouraged
to consult the study team whenever they felt ill, to check
for fever and malaria infection (blood smear and BSFP).
If malaria parasites were identified by microscopy in the
field after recruitment, participants were treated with
CQ for three days under direct supervision, and followed
up until parasite clearance (confirmed by microscopy).
Those participants with 2 or more episodes of malaria
after the recruitment were given a complete 7-day PQ
treatment before the 2 year follow up. This study was
approved by the Ethical Boards of Universidad Peruana
Cayetano Heredia, Peru (Project PVIVAX-UPCH, SIDISI
code: 053256), the Institute of Tropical Medicine Antwerp
and the University Hospital of Antwerp (Belgium).
Laboratory methods
All day 0 (D0) blood samples were analysed by microscopy
(thin and thick film) and Plasmodium species-specific
PCR (ssPCR) to confirm the presence and density of P.
vivax parasites, and this was repeated for all blood
samples taken during participants’ monthly follow-up
(scheduled and unscheduled visits). Parasite density
was computed after counting the number of asexual
parasites for 200 white blood cells (WBC) in the thick
smear and assuming a concentration of 8,000 WBCs/μl.
A slide was declared negative if no malaria parasite was
found after examining 100 fields. Quality control was
done by a senior technician on all positive and 10% of
negative slides [19].
Parasite DNA was extracted from the BSFP using the
saponin lysis Chelex 100 method [20], and either stored
at 4°C for immediate use in PCR reactions or at -20°C
for later use. All samples were first analysed by ssPCR
following a protocol published elsewhere [21]. Briefly,
this ssPCR consisted of a primary PCR with primers di-
rected to specific Plasmodium and mammal sequences,
and obtained amplicons were used for a second PCR
using Plasmodium-species specific primers.
Positive vivax malaria samples, either by microscopy
and/or species specific PCR, were selected for genotyp-
ing using 15 neutral, or nearly neutral, microsatellite
markers (MS) as described elsewhere [22,23]. This tech-
nique consists of PCR amplification of 15 microsatellite
sequences using for each reaction two specific pairs of
primers (flurophore-labelled forward primer and no la-
belled reverse primer). The PCR fragments were ana-
lysed by capillary electrophoresis in a 3730 XL ABI
sequencer (Applied Biosystems, Foster City, CA, USA).
The size of the PCR fragments was determined using
Genemapper (Applied Biosystems, Foster City, CA,
USA); bands smaller than 100 relative fluorescence units
(RFU) were defined as background. Samples presenting
no microsatellite PCR (MS PCR) amplification in some
loci were re-analysed [23].
Data analysis
Data were double entered and cleaned in Excel (Micro-
soft, USA) and then analysed with SPSS v.16 (SPSS Inc,
Chicago, IL, USA). A P. vivax recurrence was defined as
any symptomatic (i e, fever: axillary temperature >37.5°C)
or asymptomatic P. vivax infection identified by micros-
copy and/or PCR occurring between seven days and 24
months after the start of radical cure treatment. Recur-
rences were defined as “patent” if identified by micros-
copy, and “sub-patent” if detected only by ssPCR. All
sub-patent infections were assumed to have an average
parasite density of 10/μl [24]. The overall mean parasite
density (geometric means) at day zero (D0) and overall
density at monthly follow-up visits were compared by
Student’s t-test.
Genetic structure and population dynamics
An infection was defined as polyclonal (presence of two
or more genetically distinct clones) if at least one locus
presented more than one allele [25]. The percentage of
polyclonal samples detected by each locus was described.
The locus with the highest number of alleles was consid-
ered as a proxy for the ‘multiplicity of infection’ (MOI),
representing the minimal number of parasite haplotypes
in the sample [14]. Haplotypes, described as unique al-
lelic combinations of the 15 loci analysed, were deter-
mined in monoclonal samples using Genclone v2.0 [26].
The haplotypes within polyclonal samples were analysed
using both the predominant and minor alleles in the
sample (peak size in the electropherogram) and defined
respectively as the most probable dominant and minor
clones. The proportions of monoclonal/polyclonal infec-
tions in children (≤14 years old) and adults (>14 years
old) at D0 and among recurrent infections were com-
pared using Pearson chi-square test.
The total number of alleles per each locus, the allelic
richness (number of alleles per locus independently of
the sample size), the number of alleles detected in a
sample by any locus, and the genetic diversity of each
locus (expected heterozygosity (He)) were computed for
each population using FSTAT v.2.9.3 [27]. The He repre-
sents the probability of finding a different allele for a
given locus in any pair of haploids randomly drawn from
the same population. Genepop v4.0 software was used to
assess the population differentiation through the analysis
of the allele distribution [28,29].
The standardized index of association (IA
s ) was com-
puted with LIAN 3.5 software [30] and used to test
whether multilocus linkage disequilibrium (multilocus
LD) occurred in local parasite population [11,12,14]. The
IA
s was assessed among monoclonal infections, respect-
ively for D0, monthly recurrences and all samples to-
gether. In addition, pair-wise linkage disequilibrium
(pair-wise LD) was assessed between every pair of
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markers using G-statistics with FSTAT software [27] to
avoid any bias due to physical linkage between particular
loci located within the same contigs (relatively long seg-
ments of contiguous DNA sequence assembled during
genome analysis) [11]. The probability of finding identi-
cal haplotypes derived from distinct sexual reproductive
events (psex) in two or more samples was computed
using GenClone ver. 2.0 [26].
Three different approaches (eBURST, STRUCTURE
and NETWORK) were used to identify clonal parasite
groups. eBURST software v.3 [31] was used to identify
haplogroups, defined as clusters of closely related haplo-
types that are identical to each other on at least 11 loci
[13]. The haplotypes that were not related to any hap-
logroup were classified as singletons. The haplogroups
and singletons were used to analyse the transmission dy-
namics of the parasites at the genetic level over time
[11,13]. In addition, STRUCTURE v.2.3.3 was used to
identify distinct sub-populations and determine fractions
of the haplotype for each strain that belong to each sub-
population. The most probable number of clusters was
defined by calculating the K value as described elsewhere
[32]. The relationship between P. vivax haplotypes was
further analysed by a simple phylogenetic approach
using software Network v.4.6.1.0 [33].
Using the geo-coding of the participants at household
level and the SaTScan software v9.1.1 [34], space-time
scan statistics were employed to identify clusters of
space-time malaria cases with elevated proportions of
specific haplotypes. This was done by gradually scanning
a window across time and space, noting the number of
observed and expected infections inside the window at
each location. The space-time clusters were assessed
with up to a maximum of 50% of the data included in
the scanning window and a maximum temporal window
size of up to 50% of the study period. The relative risk
(RR) was computed by dividing the estimated risk within
the cluster by the estimated risk outside the cluster. The
window with the maximum likelihood is defined as the
most likely cluster. The significance of the identified
space-time clusters was tested using the likelihood ratio
test statistic and p-values were obtained through Monte
Carlo simulations [35].
Results
Baseline characteristics
In April 2008 (screening), the prevalence of vivax mal-
aria in San Carlos was estimated at 10.2% by standard
microscopy. Between April and December 2008, a total
of 37 individuals (in 20 households) were identified with
a P. vivax mono-infection and recruited into the study.
Males (n = 19) and females (n = 18) were equally repre-
sented, and the median age was 15 years (IQR 3–48)
with 40% of study participants aged < nine years. At D0
the mean parasite density was 2,031/μl (95% CI: 1,332-
3,098). Though all D0 slides were double-read by a
senior technician, the ssPCR remained negative (ssPCR
repeated once after negative amplification) for two par-
ticipants whose parasite density by microscopy was
48/μl and 823/μl, respectively. During the first 28 days
of follow-up, there was no P. vivax recurrence observed
by microscopy or by ssPCR (Figure 2).
Plasmodium vivax recurrences during the monthly
follow-up
At day 28, all 37 participants were found negative both
by microscopy and ssPCR. During the following 23-
month period, a total of 142 P. vivax recurrent infec-
tions were detected by microscopy with a mean parasite
density of 88/μl (95% CI: 56–139) which was signifi-
cantly lower than that at D0 (p < 0.001). The ssPCR
missed two recurrent infections despite a parasite dens-
ity by microscopy of 36 and 4,352/μl, respectively. By
the end of the two-year follow-up, 76% (28/37) of the
study subjects had experienced at least one recurrent P.
vivax infection, while only two Plasmodium falciparum
infections were identified. More than half of the recur-
rent infections (54.9%, 78/142) were sub-patent and
asymptomatic.
Genetic diversity of the Plasmodium vivax population
A total of 174 P. vivax infections (35 D0 and 139 recur-
rences) were genotyped by MS PCR (Figure 2), among
which 164 had a MS PCR amplification. Most of them
(82.9%, 136/164) were monoclonal and had complete al-
lele data (for all loci) (91.9%, 125/136). The proportions
of monoclonal and polyclonal infections did not differ
between baseline and recurrent infections, and neither
did the average multiplicity of infection (MOI) (Table 1).
The average expected heterozygosity (He) was 0.49
(range 0.10-0.67) (Table 1), and MS4 was the most in-
formative marker (He = 0.65) discriminating 58.6% of all
polyclonal infections. The average total number of alleles
per locus was 4.6 (range 2–7), the average allelic rich-
ness was 4.17 (range 1.99-6.28) and the average number
of alleles detected in a sample by any locus remained
constant between all loci (1.1-1.2). Average genetic in-
dexes did not vary between D0 and recurrences, how-
ever looking at specific periods of the study, differences
were found, as shown later.
Parasite inbreeding
The analysis of the monoclonal samples (n = 136)
showed a highly significant overall LD (IA
s = 0.51,
p < 0.0001) indicating a clonal population. To check for
bias due to unequal distribution of the haplotypes or
due to sampling, the LD was also assessed for unique
haplotypes only, and it remained significant (IA
s = 0.15,
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p < 0.0001). Inbreeding, rather than physical linkage
between markers established in the same contig
(MS4-MS5, MS7-MS8 and MS12-MS15), was identified
by the linkage between multiple loci obtained by pair-wise
LD analysis (Figure 3). Indeed, the probability that the
clonal population was due to reproductive events between
genetically unrelated parents was very low (psex = 0.0006).
Plasmodium vivax population structure
A total of 162 haplotypes were identified, 125 from
monoclonal and 37 from polyclonal infections, of which
20 were classified as unique haplotypes (Figures 2 and 4).
H11, H4 and H5 were the most frequent haplotypes de-
tected in 45, 15 and 16% of the infections, respectively.
Moreover, eight haplotypes were detected two to five
times (<3% each) and nine haplotypes were detected
only once. Using eBURST (criteria = 11 common loci),
four haplogroups (A, B, C, and D) containing two to
ten unique haplotypes and three singletons were identi-
fied. Similarly to eBURST, four populations (k = 4) were
inferred using STRUCTURE and were very similar to
the haplogroups previously defined by eBURST (Figure 4
and Additional file 1). The phylogenetic tree obtained
using NETWORK supported the classification results
obtained by eBURST: i) haplogroup A contained ten low
frequency, slightly different haplotypes; ii) haplogroup B,
derived from haplogroup A, contained only two haplo-
types (two extra haplotypes, H8 and H18, considered as
singletons by eBURST belonged to this group following
the classification by STRUCTURE (Pop. B); and, iii) and iv)
haplogroup C and D contained two to three haplotypes but
were dominant throughout the study (Figure 4).
Parasite dynamics and space-time clustering
The genetic diversity (He) did not vary substantially be-
tween baseline (D0) and first year monthly follow-up
samples, 0.44 and 0.40 (p = 0.26), respectively. Neverthe-
less, He was significantly higher during the second year
of follow-up (He = 0.51) compared to both baseline and
first year (p < 0.0001). In addition, compared to the first
37 Participants enrolled
D0 samples, Pv (+)*:      n = 37
ssPCR(+):  n= 35
1st year (n=66)
2nd year (n=76)
1 Pv sample was not 
analysed by  MS genotyping
MS genotyping
D0 + recurrences
n = 174 Pv samples
Monoclonal/complete allele data (n=125)
Monoclonal/incomplete allele data (n=11)
Polyclonal/complete+incomplete (n=28)
Negative PCR amplification (n=10)
Overall genetic 
diversity analysis
(n=136)
Identified 
haplotypes
(n=162)
2-year follow up after treatment
Month 1:     weekly
Month 2-4:   monthly
No Pv recurrences: 9 participants
Pv recurrences: 28 participants
Total episodes, Pv (+):       n =142
ssPCR(+):   n=140
Figure 2 Study flowchart. Thirty-seven participants were enrolled and treated (CQ + PQ) on D0. Twenty-eight participants had at least
one recurrence and nine participants had no recurrences after treatment. Only samples positive for P. vivax by ssPCR were genotyped
with 15 microsatellites (MS). In total, 162 haplotypes were detected in monoclonal and polyclonal P. vivax samples. From 28 polyclonal
infections only 37 haplotypes were identified as described in the Methods section. * = microscopically positive. Pv = P. vivax.
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year, multilocus LD (IA
s ) during the second year de-
creased from 0.6 to 0.4. The frequency of the most com-
mon haplotype at D0 and during the first year, i e, H11
(=haplogroup D), decreased substantially during the sec-
ond year (from 60 to 30%, p < 0.01), while in the same
period new infrequent haplotypes (i e, H1, H3) and other
haplotypes belonging to the haplogroup A were ob-
served (Figure 5, panel A). The frequency of the hap-
logroup C remained constant throughout the study
although its composition varied by year, H4 gradually re-
placing H5 during the second year (Figure 5, panel B).
Using SaTScan, a total of six space-time clusters of five
different haplotypes (out of 20) were identified during
the study period (Figure 6). Clusters of H11 and H5
represented the two main clusters within the first year
(RR = 10.1 and 13.5 respectively; from May to August
2008), while H4 cluster represented a significant large
cluster during the second year (RR = 9.9; from June 2009
to May 2010). In 2009, H11 was defined as a secondary
cluster, and together with two other haplotypes (H7, H8)
clustered in single households for several months. Due to
sparseness of some haplotypes in multiple households, only
Table 1 Overall polymorphism of the 15 Plasmodium vivax microsatellite loci assessed in San Carlos community
Locus Total number of alleles Allele size (range in bp) He Allelic richness Polyclonal samples/locus (%) Average alleles/locus
MS1 4 234 - 242 0.1 2.94 0% 1.1
MS2 5 187 - 207 0.6 4.89 13.8% 1.1
MS3 2 181 - 184 0.13 1.99 6.9% 1.1
MS4 5 165 - 198 0.65 4.62 58.6% 1.2
MS5 2 166 - 172 0.29 2 6.9% 1.1
MS6 5 208 - 244 0.61 4.38 17.2% 1.1
MS7 3 142 - 148 0.47 2.98 17.2% 1.1
MS8 4 252 - 271 0.6 4 24.1% 1.1
MS9 5 155 - 172 0.66 4.94 20.7% 1.1
MS10 4 210 - 266 0.13 3.19 0% 1.1
MS12 6 181 - 332 0.55 5.14 27.6% 1.1
MS15 4 210 - 256 0.59 3.98 31% 1.1
MS16 7 193 - 350 0.67 5.92 13.8% 1.1
MS20 7 194 - 241 0.65 6.28 24.1% 1.1
Pv6635 6 184 - 202 0.67 5.34 27.6% 1.1
A total of 174 P. vivax infections were analysed, including 35 D0 and 139 recurrent samples. The expected heterozygosity (He) and the allelic richness were
calculated only for monoclonal samples (n = 136).
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Figure 3 Patterns of linkage disequilibrium between pairs of microsatellite markers in the Plasmodium vivax population from San
Carlos community. (n = 136 monoclonal samples analysed). Grey shading denotes linkage disequilibrium at the 5% significance level (adjusted
p =0.00005 based on 106 permutations).
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clusters with meaningful RR (not zero nor infinity) were
reported.
Dynamics at individual level
More than two thirds of the participants (68.4%, 26/37)
had infections with one to two different haplotypes during
their follow-up period, while the remaining had infections
with three to five haplotypes (up to three different hap-
logroups or singletons). The most frequently detected
haplotype, H11, dispersed within 80% (16/20) of the par-
ticipants’ households and occurred in 60.7% (17/28) of the
participants in at least one infection (up to eight infections
with H11 in two participants).
One or more sub-patent recurrent infections that
cleared without treatment were observed in 50% (14/28)
study subjects (see Additional file 2). Some of these in-
fections had the same haplotype over several consecutive
months. During their follow-up, 60%, (9/15) of study
subjects with a H11 haplotype infection at recruitment
had several sub-patent recurrent infections with the
same haplotype.
Discussion
In San Carlos, a relatively isolated village in the Peruvian
Amazon, the majority (76%) of the 37 study participants
experienced P. vivax recurrences after radical cure given
according to the national guidelines. Most of the P. vivax
H17
H20
H19
H6
H2
H3
H16
H15
H14
H13
H12
H1H11
H10
H9
H8
H7
H5
H4
H18
Haplogroup B
Haplogroup D
Haplogroups
First year follow-up
Second year follow-up
Singleton
Figure 4 A median joining tree performed using NETWORK representing the relationship between Plasmodium vivax haplotypes and
their temporal distribution. Each circle represents a different haplotype and the size reflects the frequency of detection within the two years
(n = 162). Related haplotypes are linked by a line and mutations (о). Solid lines denote the haplogroups obtained using eBURST v.3 and
STRUCTURE v.2.3.3 (Pop A, B, C, D).
Delgado-Ratto et al. Malaria Journal 2014, 13:8 Page 7 of 12
http://www.malariajournal.com/content/13/1/8
recurrences were sub-patent and asymptomatic, some of
them persisting for several months. Such a high occur-
rence of recurrent infections after treatment with a full
course of PQ has already been observed in several other
South American endemic countries [13,36-39]. The large
proportion of monoclonal P. vivax infection found in this
study was similar to that reported from Colombia [40] but
different compared to other communities in the Peruvian
Amazon [14] and other areas in South and Central
America [11,12]. This is probably due to the differences in
effective recombination rates and in human and vector be-
haviour. The clonality of the parasite population in San
Carlos was confirmed by the highly significant LD. The
latter can be due to either the low rate of recombination
(inbreeding) or the recent occurrence of admixture of two
unrelated genotypes that did not have sufficient time to
homogenize [41]. Though the latter is theoretically pos-
sible, considering the strong differentiation between mal-
aria parasite populations over relatively small geographical
distances reported in South America [11,42,43], the low
probability of admixture (psex) found in San Carlos indi-
cates that inbreeding was the most likely reproductive
event in this area. This was also the case in other reports
from endemic areas of the Amazon Basin [11,13,43]. In-
breeding could also explain the replacement of haplotypes
without haplogroup replacement as it was observed in this
study with the highly prevalent haplogroup C.
Clustering of malaria transmission at household level
has been previously reported in the Peruvian Amazon
[6,14]. In the present study, malaria infections carrying
the same haplotype, or haplotypes from the same hap-
logroup, were identified concurrently or within a period
of a few weeks in participants living in the same house-
holds. The persistence of infections with the same
haplotype for long periods, also due to the relapsing
nature of P. vivax [44,45], can maintain a certain level
of immunity even in low transmission areas like the
Amazon Basin [46].
The clustering of haplotypes may also influence the
parasite diversity and the interpretation of recurrent
parasitaemia. Some participants carried the same haplo-
type for several consecutive months, and later presented
a new but closely related haplotype (Additional file 2).
Previous studies have reported also a high rate of
Figure 5 Transmission dynamics of Plasmodium vivax haplotypes and haplogroups in San Carlos community. Panel A: Monthly
distribution of the 162 P. vivax haplotypes found among 164 P. vivax infections (patent and sub-patent) between April 2008 and June 2010.
Twenty unique haplotypes were detected and are represented by different colours. Panel B: Monthly distribution of the haplogroups containing
closely related haplotypes determined using eBURST. Composition of each haplogroup: A (H1, H2, H3, H6, H12, H13, H14, H15, H16, H19), B (H17,
H20), C (H4, H5), D (H9, H10, H11), singletons (H7, H8, H18).
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genetically similar recurrent infections in the Peruvian
Amazon [44,47]. It was not possible to determine
whether this genetic variation originated within the mos-
quito or the human host. Nevertheless, considering the
low transmission in San Carlos, it is likely that most re-
currences were not new infections, but rather relapses
or recrudescences. For example, haplotypes H4 and H5
(distributed in 8/20 and 14/20 households, respectively)
infected participants living within the same households
(in seven households in total). H4 and H5 belong to the
same haplogroup and they differ by only one locus
(MS8, alleles of 258 and 271 bp, respectively). As most
of the P. vivax microsatellite diversity is produced within
the human host during the mitotic replication [48-50]
and considering that H4 displaced H5 in the second
year, deletion of repeat units may have caused the haplo-
type differentiation in the human host. If this is the case,
the recurrence of heterologous parasites may not be
necessarily due to previous infection(s) with multiple
different clones [51] but to genetic variation of one para-
site clone within the human host. In addition, homolo-
gous parasites in recurrent infections may represent
relapses of a limited diversified parasite population or
non-hypnozoite stages (i.e., parasite stages within splenic
dendritic cells) that re-activate after extended periods of
latency [5,52,53].
Clonal population: possible implications for malaria
epidemiology
Due to the clonality and clustering of the parasite popu-
lation in San Carlos, people were repeatedly exposed to
the same strains. According to the model of strain-
specific immunity to malaria [10,54], effective malaria
immunity in low transmission areas may be achieved
after a relatively small number of infective mosquito
bites [41]. In addition, in areas with low levels of recom-
bination, haplotypes may be maintained through multiple
generations [41], continuously exposing their antigens to
the human immune system [2]. In San Carlos, most partici-
pants were asymptomatic to the most frequent haplotype,
H11, possibly due to the development of clinical immunity
that was able to control the parasite density and prevent
symptoms. Therefore, the limited genetic diversity and the
low MOI in this low transmission area may still stimulate
an efficient immune response [10] which could explain the
common occurrence of asymptomatic and sub-patent
infections.
In relatively isolated populations such as San Carlos,
with few circulating clones, continued anti-malaria treat-
ment/drug pressure may foster a genetic restructuring of
the parasite population, favouring the spread of the drug
resistance trait [9]. No indication of CQ resistance was
found in the present study. However the frequent
Study house
No study house
Figure 6 Aerial view of San Carlos depicting the location of the three major space-time primary clusters of Plasmodium vivax
haplotypes (H11, H5 and H4) and a description of all the significant clusters found during the follow up. Households mapped with GPS
on Google Maps. a Number of households by cluster; b Secondary cluster; Obs = observed number of cases; Exp = expected number of cases;
RR = relative risk; LLR = log likelihood ratio. Radius in meters (m). *H4 cluster from June 2009 until May 2010.
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occurrence of recurrent infections with similar haplo-
types after one month the radical treatment was given
could be an early sign that the PQ is not working
efficiently, probably due to resistant parasites or ineffi-
cient metabolic activation of the PQ by the participants.
Further studies involving a larger number of endemic
communities, with different rates of recurrences and
parasite population structure, as well as the use of
in vitro studies, resistance markers and whole parasite
genome sequencing would give more insights on the rise
and spread of resistant parasites and the parasitic genetic
diversity.
Conclusions
Combining population genetic tools and space-time scan
statistics allowed for an in-depth insight to the dynamics
of P. vivax clones at individual and household level in this
isolated community of the Peruvian Amazon. Space-time
clustering of recurrent asymptomatic P. vivax infections
with few specific clones reflects the highly focal transmis-
sion of the local parasite population favouring the develop-
ment of clinical immunity by infected people. This type of
setting could also be at high risk of selection and spread if
drug resistant P. vivax clones are under high selective pres-
sure. This type of information is highly valuable for further
strengthening malaria elimination strategies in the Peruvian
Amazon and should be extended to different endemic
areas.
Additional files
Additional file 1: Population structure inferred by microsatellite
genotyping of 136 Plasmodium vivax monoclonal infections using
STRUCTURE. Panel A, using the method described elsewhere [32], the
uppermost hierarchical level of structure was assumed, describing four
populations (highest peak, K = 4). Two other peaks (K = 6 and K = 9) are
described with a lower likelihood. K = 6 corresponded to the six
haplogroups defined by eBURST when the criteria of relatedness was
increased to 14 loci instead of 11. Panel B illustrates the bar plot at K = 4
with 136 samples being represented by a single vertical line divided into
colours assigned to the population of origin. Each colour represents one
population (A-green, B-blue, C-red, D-yellow), and the length of the
coloured segment shows the estimated proportion of membership of
that sample to each population.
Additional file 2: Characteristics of each malaria infection suffered
by the 37 participants. X = Initial infection in this study (D0). Green
shading indicates a recurrent P. vivax infection. P = patent infection. On
the upper left corner of the cells is defined the haplotypes (H1…H20) or
one of the symbols explained below. i = incomplete allele data, m =
mixed infections (not possible to differentiate the haplotypes). ind =
haplotype within a mixed infection that cannot be determined. n = P.
vivax sample that did not amplified by PCR with any of the
microsatellites. † Patent infection detected by microscopy but no by
ssPCR (MS genotyping was not done). ⱡ Pv positive by microscopy on D0
but filter paper D0 was not available. On day 1 was negative by ssPCR
(MS genotyping was not performed).
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